Article
The polyphenols (-)-epigallocatechin-3-gallate and luteolin synergistically inhibit TGF-β-induced myofibroblast phenotypes through RhoA and ERK inhibition.
PloS one - 1 Jan 2014
Gray Alana L, Stephens Charles A, Bigelow Rebecca L H, Coleman David T, Cardelli James A
Abstract excerpt
The presence of reactive stroma, predominantly composed of myofibroblasts, is directly associated with and drives prostate cancer progression. We have previously shown that (-)-Epigallocatechin-3-gallate (EGCG), in the form of Polyphenon E, significantly decreases serum levels of HGF and VEGF in prostate cancer patients. Given that HGF and VEGF are secreted from surrounding tumor myofibroblasts, these...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
